|
Help us fund research
that is changing lives 
Let us know about a "star" employee:  |
Active Research Studies Active Research Studies:AADC Gene Therapy for Parkinson’s Disease Closed to Recruitment Principal Investigator: Paul Larson, M.D. Contact: Marin Thompson, MS, CCRP 415-353-9666 .(JavaScript must be enabled to view this email address) A Phase 2A Safety and Biomarker Study of EPI-589 in Subjects with Mitochondrial Subtype and Idiopathic Parkinson’s Disease Principal Investigators: Caroline Tanner, M.D., Ph.D. and Jill Ostrem, M.D. Contact: Danilo.Romero, B.A. 415-353-8328 .(JavaScript must be enabled to view this email address) A Randomized, Placebo Surgery Controlled, Double-blinded, Multi-center, Phase 2 Clinical Trial, Evaluating the Efficacy and Safety of VY-AADC02 in Advanced Parkinson’s Disease with Motor Fluctuations Principal Investigator: Chadwick Christine, M.D. Co-Principal Investigator: Paul Larson, M.D. Contact: Marin Thompson, MS., CCRP 415-353-9666 .(JavaScript must be enabled to view this email address) Computer-assisted Automated Deep Brain Stimulation Programming for Patients with Movement Disorders Principal Investigator: Jill Ostrem, M.D., Svjetlana Miocinovic, M.D., Ph.D., and Kyle Mitchell, M.D. Contact: Kyle Mitchell, M.D. .(JavaScript must be enabled to view this email address) Chronic Effects of Deep Brain Stimulation on Cortical Local Field Potentials in Parkinson’s disease and Dystonia (Activa PC+S /Brain Radio) Principal Investigator: Philip Starr, M.D., Ph.D. Contact: Sheila Rajagopalan, B.A. .(JavaScript must be enabled to view this email address) Colonoscopy Biopsy and Alpha-Synuclein in Premotor PD Principal Investigators: Samuel Goldman, Ph.D. and Caroline Tanner, M.D., Ph.D. Not enrolling Cortical Recordings to Evaluate Anxiety, Depression and Impulsivity in Parkinson’s Disease Patients Principal Investigator: Philip Starr, M.D., Ph.D. and Coralie De Hemptinne, Ph.D. Contact: Coralie De Hemptinne, Ph.D. .(JavaScript must be enabled to view this email address) Deep Brain Stimulation for Movement Disorders: Study of Patient Outcomes Principal Investigator: Jill Ostrem, M.D. Contact: Kristen Dodenhoff, B.A. 415-353-1555 .(JavaScript must be enabled to view this email address) Deep Brain Stimulation in Area LC for Chronic Tinnitus Principal Investigators: Paul Larson, M.D. and Steven Cheung, M.D. Contact: Sarah Wang, Ph.D. 415-353-7885 .(JavaScript must be enabled to view this email address) Delivery of Psychiatric Care to Patients with Parkinson’s Disease Using Telemedicine Principal Investigators: Andreea Seritan, M.D. and Jill Ostrem, M.D. Contact: Danilo.Romero, B.A. 415-353-8328 .(JavaScript must be enabled to view this email address) Does Outpatient Palliative Care Improve Patient-Centered Outcomes in Parkinson’s Disease? Movement Disorders Center Supportive Care Clinic Principal Investigators: Maya Katz, M.D. and Nicholas Galifianakis, M.D., M.P.H. Contact: Kevin Park, MBBS 415-353-9453 .(JavaScript must be enabled to view this email address) Effects of Deep Brain Stimulation for Parkinson’s disease on Tinnitus Principal Investigators: Paul Larson, M.D. and Steven Cheung, M.D. Contact: Sarah Wang, Ph.D. 415-353-7885 .(JavaScript must be enabled to view this email address) Endotoxin Exposure and Risk of Parkinsonism Principal Investigator: Caroline Tanner, M.D., Ph.D. Not enrolling FOUND in PPMI (Follow Up of People with Neurodegenerative Diseases) Principal Investigators: Samuel Goldman, Ph.D. and Caroline Tanner, M.D., Ph.D. Contact: Kathleen Comyns, M.P.H. .(JavaScript must be enabled to view this email address) Functional and Structural Differences in Brain Connectivity between Primary and Secondary Dystonia in Children and young Adults Principal Investigators: Amy Viehoever, M.D., Ph.D. Contact: Kristen Dodenhoff, B.A.. 415-353-9453 .(JavaScript must be enabled to view this email address) Genetics of Movement Disorders Principal Investigators: Marta San Luciano, M.D., M.S. and Jill Ostrem, M.D. Contact: Kristen Dodenhoff, B.A. 415-353-1555 .(JavaScript must be enabled to view this email address) Implantable Neurostimulator for the Treatment of Parkinson’s disease (Boston Scientific INTREPID Study) Principal Investigators: Jill Ostrem, M.D. and Philip Starr, M.D., Ph.D. Contact: Danilo.Romero, B.A. 415-353-8328 .(JavaScript must be enabled to view this email address) LRRK2 Environmental Analysis Principal Investigator: Caroline Tanner, M.D., Ph.D. Data analysis only; not enrolling Medications for Movement Disorders Principal Investigator: Jill Ostrem, M.D. and Karen Merchant Not enrolling More Than a Movement Disorder: Applying Palliative Care to Parkinson’s Disease Principal Investigator: Nicholas Galifianakis, M.D., M.P.H. and Maya Katz, M.D. Contact: Jana Guenther, B.A. 415-514-8273 .(JavaScript must be enabled to view this email address) MtDNA Damage as a Biomarker for Environmental Mitochondrial Toxicity Principal Investigators: Samuel Goldman, Ph.D. and Caroline Tanner, M.D., Ph.D. Not enrolling Non-Invasive Scalp EEG to study Brain Circuits in Movement Disorders Principal Investigator: Philip Starr, M.D., Ph.D. Contact: Sheila Rajagopalan, B.A. .(JavaScript must be enabled to view this email address) The Parkinson’s Progression Markers Initiative (PPMI) Principal Investigator: Caroline Tanner, M.D., Ph.D. Contact: Farah Kausar, Ph.D. .(JavaScript must be enabled to view this email address) PD in the Honolulu Asia Aging Study Principal Investigator: Caroline Tanner, M.D., Ph.D. Not enrolling Physiology of the Basal Ganglia and Thalamus Principal Investigator: Philip Starr, M.D., Ph.D. Contact: Sheila Rajagopalan, B.A. .(JavaScript must be enabled to view this email address) Polychlorinated Biphenols and PD, a Case Control Study in Alaska Natives Principal Investigators: Caroline Tanner, M.D., Ph.D. and Samuel Goldman, Ph.D. Data analysis only; not enrolling Possible Effects of Solvents in Bay Area Auto Workers (BASS-S) Principal Investigator: Caroline Tanner, M.D., Ph.D. Contact: Kathleen Comyns, M.P.H. .(JavaScript must be enabled to view this email address) Rechargeable Implantable Pulse Generator (IPG) for Deep Brain Stimulation (DBS): Patient Satisfaction and Experience Principal Investigator: Jill Ostrem, M.D., Monica Volz, N.P., and Kyle Mitchell, M.D. Contact: Kyle Mitchell, M.D. .(JavaScript must be enabled to view this email address) Safety and Efficacy of VY-AADC01 for Advanced Parkinson's Disease Closed to Recruitment Principal Investigator: Paul Larson, M.D. Contact: Marin Thompson, MS, CCRP 415-353-9666 .(JavaScript must be enabled to view this email address) Thalamic DBS for Secondary Dystonia Principal Investigators: Amy Viehoever, M.D., Ph.D. Contact: Kristen Dodenhoff, B.A.. 415-353-9453 .(JavaScript must be enabled to view this email address) Trichloroethylene and Parkinson’s diease Principal Investigators: Caroline Tanner, M.D., Ph.D. and Samuel Goldman, Ph.D. Data analysis only; not enrolling MDNC - Completed Research Studies Deep Brain Stimulation in Patients with Dystonia (STN DBS) Principal Investigators: Jill Ostrem, M.D. and Philip Starr, M.D., Ph.D. Contact: Kristen Dodenhoff, B.A. 415-353-1555 .(JavaScript must be enabled to view this email address) Epidemiology of Dystonia in a Multiethnic Population: Diagnostic Delay in Dystonia Principal Investigators: Sara LaHue, M.D., Erica Byrd, M.D., Samuel Goldman, Ph.D., and Caroline Tanner, M.D., Ph.D. Contact: Sara LaHue, M.D./Erica Byrd, M.D. .(JavaScript must be enabled to view this email address) .(JavaScript must be enabled to view this email address) Interventional MRI (iMRI) for implantation of Deep Brain Stimulator Electrodes Principal Investigators: Philip Starr, M.D., Ph.D., Paul Larson, M.D., Alastair Martin, Ph.D., and Jill Ostrem, M.D. Contact: Sarah Wang, Ph.D. 415-353-7885 .(JavaScript must be enabled to view this email address) Interventional MRI (iMRI) Patient Satisfaction and Experience Principal Investigators: Sara LaHue, M.D., Maya Katz, M.D., and Jill Ostrem, M.D. Contact: Sara LaHue, M.D. .(JavaScript must be enabled to view this email address) NAC CSF Biomarker Study Principal Investigator: Maya Katz, M.D. Contact: Maya Katz, M.D. 415-353-7631 .(JavaScript must be enabled to view this email address) Prodromal features of PD, DLB, MSA, PSP Principal Investigators: Sara LaHue, M.D., Samuel Goldman, Ph.D., and Caroline Tanner, M.D., Ph.D. Contact: Sara LaHue, M.D. .(JavaScript must be enabled to view this email address) RACE PD - Remote Access to Care, Everywhere: Using Telemedicine to Deliver Patient-Centered Care to Patients with Parkinson’s disease Principal Investigators: Nicholas Galifianakis, M.D., M.P.H. and Caroline Tanner, M.D., Ph.D. Contact: Danilo.Romero, B.A. 415-353-8328 .(JavaScript must be enabled to view this email address) Safety and Effectiveness of Cala ONE Device for Essential Tremor Principal Investigators: William Marks, Jr., M.D., Cameron Dietiker, M.D., and Nijee Luthra, M.D., Ph.D. Contact: Kristen Dodenhoff, B.A./Michael Dodge, B.A. 415-353-1555/415-353-8328 .(JavaScript must be enabled to view this email address)/Michael.Dodge@ucsf.edu Survey of Technology-Related Impulse Control Disorders in Parkinson’s disease Principal Investigators: Nicholas Galifianakis, M.D., M.P.H. and Erica Byrd, M.D. Contact: Danilo Romero, B.A. 415-353-8328 .(JavaScript must be enabled to view this email address) Thalamic Deep Brain Stimulation for Secondary Dystonia in Children and Young Adults Principal Investigator: Amy Viehoever, MD, PhD Contact: Kristen Dodenhoff, BA Phone: 415-353-1555 Email: .(JavaScript must be enabled to view this email address) Trichloroethylene and Parkinson’s diease Principal Investigators: Caroline Tanner, M.D., Ph.D. and Samuel Goldman, Ph.D. Data analysis only; not enrolling St. Jude/ANS Libra Deep Brain Stimulation System for Patients with Essential Tremor Principal Investigator: Jill Ostrem, M.D. Contact: Monica Volz, N.P. .(JavaScript must be enabled to view this email address) Use of Liftware Spoon Device for Non-Invasive Measurement and Reduction of Hand Tremor Principal Investigators: Jill Ostrem, M.D. and Svjetlana Miocinovic, M.D., Ph.D. Contact: Sarah Wang, Ph.D. 415-353-7885 .(JavaScript must be enabled to view this email address) |
| Neurology Clinical Programs |
|
